Tag: Radiotherapy
-
Two-Dose Radiation Could Transform Prostate Cancer Treatment
New Findings Could Shorten Prostate Cancer Treatment Recent research from Rabin Medical Center-Beilinson Campus in Petah Tikva is drawing attention for suggesting that some prostate cancer patients might benefit from an extremely short course of radiation therapy—potentially as few as two doses. While the details are still being reviewed by the medical community, the concept…
-
KIRAN Inaugurates Second Halcyon LINAC in Karachi
KIRAN Expands Radiotherapy Capabilities with a Second Halcyon LINAC In a landmark move for cancer care in Pakistan, the Karachi Institute of Radiotherapy and Nuclear Medicine (KIRAN) has inaugurated its second Halcyon Linear Accelerator (LINAC). Operated by the Pakistan Atomic Energy Commission (PAEC), KIRAN is the country’s largest public-sector cancer hospital, renowned for delivering advanced…
-
KIRAN Hospital Expands Radiotherapy with Its Second Halcyon LINAC
Introduction: A milestone for public-sector cancer care Karachi Institute of Radiotherapy and Nuclear Medicine (KIRAN), the country’s largest public-sector cancer hospital operated by the Pakistan Atomic Energy Commission (PAEC), has officially inaugurated its second Halcyon Linear Accelerator (LINAC). This expansion marks a significant step in widening access to cutting-edge radiotherapy for patients across Pakistan, reinforcing…
-
KIRAN inaugurates its second Halcyon LINAC to expand radiotherapy services in Karachi
KIRAN expands radiotherapy capacity with a second Halcyon LINAC Karachi Institute of Radiotherapy and Nuclear Medicine (KIRAN), the largest public-sector cancer hospital operated by the Pakistan Atomic Energy Commission (PAEC), has unveiled its newest achievement in the fight against cancer: a second Halcyon Linear Accelerator (LINAC). The installation marks a significant milestone in Pakistan’s public…
-
SUPREMO Trial: Rethinking Postmastectomy Radiotherapy
Overview: A Shift in Postmastectomy Strategy The international phase 3 SUPREMO trial is reshaping how clinicians treat intermediate-risk early breast cancer (eBC) after mastectomy. The study, officially registered as ISRCTN61145589, investigated whether omitting chest-wall irradiation could maintain survival outcomes while reducing treatment-related toxicity. Historically, postmastectomy radiotherapy (PMRT) has been standard care for various levels of…
-
In Focus: Late Detection of Prostate Cancer and the PSA Blood Test
Understanding Why Prostate Cancer Often Surfaces Late Prostate cancer is one of the most common cancers among men, yet it remains a disease that many people fear or misunderstand. A key issue is late detection. While some tumors grow slowly and cause few symptoms, others advance quietly until they are harder to treat. Delays in…
-
In Focus: Late Detection of Prostate Cancer and the PSA Test Debate
Understanding the PSA Test and Why It Matters Prostate cancer is a leading health concern for men, and early detection can dramatically change outcomes. The prostate-specific antigen (PSA) blood test is a common screening tool used to flag potential trouble in the prostate. Yet many men—and some clinicians—are hesitant about routine PSA testing. Concerns about…
-
In Focus: Why Men Skip the PSA Blood Test for Prostate Cancer and What Happens Next
Understanding the PSA Test and Early Detection The PSA (prostate-specific antigen) blood test is a simple screening tool designed to help detect potential prostate cancer before symptoms appear. Because the disease can progress quietly, early detection often leads to more treatment options and better outcomes. Yet, many men delay or decline PSA testing for a…
-
Global Analysis Reveals Stark Inequalities in Care for Breast, Cervical, and Ovarian Cancers
New Global Findings Highlight Widespread Inequities in Cancer Care A landmark study by the Cancer Survival Group at the London School of Hygiene & Tropical Medicine reveals persistent and troubling inequalities in how women’s cancers—breast, cervical, and ovarian—are diagnosed and treated around the world. The research, which analyzed data from diverse health systems, shows that…
-
Pembrolizumab Doubles Survival in Advanced Head and Neck Cancer
The Breakthrough: A New Immunotherapy Redefines Outcomes in Locally Advanced Head and Neck Cancer Locally advanced head and neck cancer poses a formidable challenge. In many patients, the disease is detected at a stage where surgery, radiotherapy, and chemotherapy are the mainstays of treatment, yet recurrence and progression remain common. A recent advance in immunotherapy,…